Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9 nuclease system has provided a powerful tool for genome engineering. Double strand breaks may trigger nonhomologous end joining repair, leading to frameshift mutations, or homology-directed repair using an extrachromosomal template. Alternatively, genomic deletions may be produced by a pair of double strand breaks. The efficiency of CRISPR/Cas9-mediated genomic deletions has not been systematically explored. Here, we present a methodology for the production of deletions in mammalian cells, ranging from 1.3 kb to greater than 1 Mb. We observed a high frequency of intended genomic deletions. Nondeleted alleles are nonetheless often edited with inversions or small insertion/deletions produced at CRISPR recognition sites. Deleted alleles also typically include small insertion/deletions at predicted deletion junctions. We retrieved cells with biallelic deletion at a frequency exceeding that of probabilistic expectation. We demonstrate an inverse relationship between deletion frequency and deletion size. This work suggests that CRISPR/Cas9 is a robust system to produce a spectrum of genomic deletions to allow investigation of genes and genetic elements.

          Related collections

          Author and article information

          Journal
          J. Biol. Chem.
          The Journal of biological chemistry
          American Society for Biochemistry & Molecular Biology (ASBMB)
          1083-351X
          0021-9258
          Aug 01 2014
          : 289
          : 31
          Affiliations
          [1 ] From the Harvard Medical School.
          [2 ] From the Harvard Medical School, the Division of Hematology/Oncology, Boston Children's Hospital, the Department of Pediatric Oncology, Dana-Farber Cancer Institute.
          [3 ] the Division of Hematology/Oncology, Boston Children's Hospital.
          [4 ] From the Harvard Medical School, the Division of Hematology, Brigham and Women's Hospital, and.
          [5 ] the Division of Hematology, Brigham and Women's Hospital, and.
          [6 ] From the Harvard Medical School, the Division of Hematology/Oncology, Boston Children's Hospital, the Department of Pediatric Oncology, Dana-Farber Cancer Institute, the Division of Hematology, Brigham and Women's Hospital, and.
          [7 ] From the Harvard Medical School, the Division of Hematology/Oncology, Boston Children's Hospital, the Department of Pediatric Oncology, Dana-Farber Cancer Institute, the Howard Hughes Medical Institute, Boston, Massachusetts 02115 Stuart_Orkin@dfci.harvard.edu.
          Article
          M114.564625
          10.1074/jbc.M114.564625
          4118095
          24907273
          e7a8962d-9754-4690-a60c-99b14a0daa6f
          History

          CRISPR,Cas9,Gene Expression,Gene Knock-out,Gene Regulation,Genetics,Genome Engineering,Genomic Deletion,Genomics

          Comments

          Comment on this article